$DXCM Sets Its Sights on $100 After Clearing Key Resistance

$DexCom(DXCM)$

$DexCom, Inc.(DXCM) +2.35% Hits 52-Week High at $92.56, Breakout Above $92.43 Resistance Activates $95–$100 Target Zone 🚀

Latest Close Data DXCM closed at $92.34 (+2.35%) on Aug 24, 2026, matching its 52-week high of $92.56 intraday. Price now sits just 0.24% below that high, with after-hours action pushing to $92.50 — a decisive breakout signal above the prior $92.43 resistance shelf.

Core Market Drivers Q2 earnings (Jul 31) remain the primary catalyst: EPS of $0.70 beat by $0.09 (+45.8% YoY), revenue of $13.08B exceeded consensus, and full-year guidance was raised to $51.8–$52.5B on strong continuous glucose monitor demand. Short volume has contracted sharply from 1.54M (Aug 11) to 537K (Aug 21), indicating bearish conviction fading.

Technical Analysis 📊 Volume came in at 3.48M shares with a volume ratio of 0.69 — not explosive, but consistent with healthy accumulation. MACD remains firmly bullish: DIF 4.235 > DEA 4.048, with histogram expanding to +0.375, confirming momentum. RSI(6) has surged to 76.50, RSI(12) at 71.15, and RSI(24) at 66.34 — all in bullish territory, though the 6-period reading flags near-term overbought risk. KDJ shows J-line at 88.66 curling upward, supporting short-term continuation.

Key Price Levels 🟢 Primary Support: $89.20 (today's low, also near 5-day pivot) 🔴 Strong Resistance: $92.43–$92.56 (52-week high zone; breakout confirmation needed) ⚡ Immediate Pivot: $90.22 (yesterday's close, now acting as first pullback floor)

Valuation Perspective P/E (TTM) at 36.41x sits below its historical average of 47.18x and well under the +1 Std.Dev of 66.23x. Forward P/E of 34.62x remains attractive for a high-growth med-tech compounder. P/S of 7.01x and P/B of 13.29x reflect premium pricing power in CGM.

Analyst Targets 25 analysts cover DXCM with average target of $93.88 (range $75–$115). Rating distribution: 13 Strong Buy, 13 Buy, 4 Hold — zero sells, underscoring institutional conviction.

Weekly Outlook Expect consolidation between $89.20–$92.56 before a decisive breakout. A daily close above $92.56 activates the $95–$100 measured move; failure to hold $90.22 risks a pullback to $89.20, then $87.50. Momentum favors bulls given MACD expansion and short-covering potential. 📈

Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. Markets involve risk; past performance does not guarantee future results.

🎯 $DexCom, Inc.(DXCM) Options Strategy: Bull Call Spread (Vertical Debit Spread)

  • Underlying: DXCM (DexCom, Inc.)

  • View: Cautiously bullish — breakout above $92.43 resistance, momentum favors continuation toward $95–$100 target zone

  • Strategy Type: Debit spread / Directional bullish with defined risk

  • Option Contract Portfolio:

    • Buy 1x DXCM 2026-09-04 $92 Call @ $2.425 (mid)

    • Sell 1x DXCM 2026-09-04 $95 Call @ $1.675 (mid)

  • Max Gain & Loss:

    • Max Gain: $175 per spread ( = $3.00 width − $1.25 net debit, ×100 shares)

    • Max Loss: $125 per spread (net debit paid, ×100 shares)

  • Initial Cost/Credit: Net Debit = $0.75 per share ($75 per spread, using mid prices: $2.425 − $1.675 = $0.75; note: wider quoted spreads exist, use limit orders to target mid)

🐯🪙 Share your choice and reasoning in the comments — thoughtful views may receive Tiger Coins!


Good allocation isn’t just about investing — it’s also about keeping everyday life organised.

Just like a well-balanced portfolio, the right organisation can make business trips, travel and workouts a little easier. The new Tiger Toiletry Bag features a dual-layer dry & wet separation design with plenty of space to keep your essentials neatly organised, wherever you go.

Redeem the new Tiger Toiletry Bag now in Tiger Coin Mall. https://laohu8.com/J/redeemGift?goodID=100538&type=delivery

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet